Samuel Barker

Dr. Samuel L.
Barker is an Independent Director at Lexicon Pharmaceuticals, Inc. He is on the Board of Directors at Lexicon Pharmaceuticals, Inc., Canvas Energy LLC and Rutgers Cancer Institute of New Jersey.
Dr. Barker was previously employed as a Chairman by Cyclacel Pharmaceuticals, Inc., an Independent Director by Cadence Pharmaceuticals, Inc., a President & Chief Executive Officer by Clearview Projects, Inc., a President by United States Pharmaceutical Group LLC, an EVP-Worldwide Franchise Management & Strategy by Bristol Myers Squibb Co., and an Executive Vice President by Worldwide Franchise Systems, Inc. He also served on the board at AtheroGenics, Inc. He received his undergraduate degree from Henderson State University (Arkansas), a graduate degree from The University of Arkansas and a doctorate degree from Purdue University.